【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Market Landscape
06.1 Market Overview
07.Global Active Pharmaceutical Ingredients Market
07.1 Market Size and Forecast
07.2 Five Forces Analysis
08.Market Segmentation by Type of Production Process
08.1 Global Market for Synthetically Produced Active Pharmaceutical Ingredients
08.1.1 Market Size and Forecast
08.2 Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients
08.2.1 Market Size and Forecast
08.2.2 Market Segmentation by Type of Product
09.Market Segmentation by Type of Product
09.1 Global High-potency Active Pharmaceutical Ingredients Market
09.1.1 Market Size and Forecast
09.1.2 Market Segmentation by Type of Production Process
09.1.3 Market Segmentation by Type of Product
10.Market Segmentation by Type of Player
10.1 Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product
11.Geographical Segmentation
11.1 Active Pharmaceutical Ingredients Market in Americas
11.1.1 Market Size and Forecast
11.2 Active Pharmaceutical Ingredients Market in APAC Region
11.2.1 Market Size and Forecast
11.3 Active Pharmaceutical Ingredients Market in EMEA Region
11.3.1 Market Size and Forecast
12.Key Leading Countries
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.2 Key Vendors 2014
20.3 Other Prominent Vendors
20.3.1 Abbott Laboratories
20.3.2 Actavis
20.3.3 Aesica
20.3.4 Albemarle
20.3.5 AMPAC Fine Chemicals
20.3.6 Anhui Biochem United Pharmaceutical
20.3.7 Anuh Pharma
20.3.8 Aptuit
20.3.9 AstraZeneca
20.3.10 Biocon
20.3.11 Bristol-Myers Squibb
20.3.12 Calyx Chemicals & Pharmaceuticals
20.3.13 Cambrex
20.3.14 Cilag
20.3.15 CIRON Drugs and Pharmaceuticals
20.3.16 CTX Life Sciences
20.3.17 Dishman Pharmaceuticals & Chemicals
20.3.18 Dr. Paul Lohmann
20.3.19 Emcure Pharmaceuticals
20.3.20 Farmabios
20.3.21 F. Hoffmann-La Roche
20.3.22 GlaxoSmithKline
20.3.23 Guilin Pharmaceutical
20.3.24 Hetero Drugs
20.3.25 Hospira
20.3.26 Ipca Laboratories
20.3.27 Janssen Pharmaceutica
20.3.28 Johnson Matthey
20.3.29 Laurus Labs
20.3.30 Lupin
20.3.31 Mallinckrodt Pharmaceuticals
20.3.32 Mangalam Drugs & Organics
20.3.33 Merck
20.3.34 Mylan
20.3.35 Novartis
20.3.36 Novasep
20.3.37 Pen Tsao Chemical Industry
20.3.38 Pfizer
20.3.39 Ranbaxy Laboratories
20.3.40 Royal DSM
20.3.41 Sanofi-Aventis
20.3.42 Sequent Scientific
20.3.43 Shanghai Desano Chemical Pharmaceutical
20.3.44 Shasun
20.3.45 Shijiazhuang Lonzeal Pharmaceuticals
20.3.46 Sigma-Aldrich
20.3.47 ST Pharm
20.3.48 Sun Pharmaceutical Industries
20.3.49 WuXi AppTec
20.3.50 Zhejiang Langhua Pharmaceutical
20.3.51 Zhuhai Rundu Pharmaceutical
21.Key Vendor Analysis
21.1 Aurobindo Pharma
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation
21.1.4 Geographical Segmentation by Revenue 2014
21.1.5 Business Strategy
21.1.6 Recent Developments
21.1.7 SWOT Analysis
21.2 BASF
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business/Product Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Boehringer Ingelheim
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2013
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Geographical Segmentation by Revenue 2013
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 Cipla
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Product Segmentation
21.4.4 Geographical Segmentation by Revenue 2014
21.4.5 Business Strategy
21.4.6 Recent Developments
21.4.7 SWOT Analysis
21.5 Dr. Reddy’s Laboratories
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2014
21.5.4 Business Segmentation by Revenue 2013 and 2014
21.5.5 Geographical Segmentation by Revenue 2014
21.5.6 Business Strategy
21.5.7 Recent Developments
21.5.8 SWOT Analysis
21.6 Lonza Group
21.6.1 Key Facts
21.6.2 Business Overview
21.6.3 Business Segmentation by Revenue 2013
21.6.4 Business Segmentation by Revenue 2012 and 2013
21.6.5 Geographical Segmentation by Revenue 2013
21.6.6 Business Strategy
21.6.7 Recent Developments
21.6.8 SWOT Analysis
21.7 Teva Pharmaceutical Industries
21.7.1 Key Facts
21.7.2 Business Overview
21.7.3 Business Segmentation
21.7.4 Business Segmentation by Revenue 2013
21.7.5 Business Segmentation by Revenue 2012 and 2013
21.7.6 Sales by Geography
21.7.7 Business Strategy
21.7.8 Key Developments
21.7.9 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Active Pharmaceutical Ingredients Market Segmentation
Exhibit 3: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process
Exhibit 4: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product
Exhibit 5: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player
Exhibit 6: Global Active Pharmaceutical Ingredients Market Segmentation by Geography
Exhibit 7: Global Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
Exhibit 8: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
Exhibit 9: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014-2019
Exhibit 10: Global Market for Synthetically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
Exhibit 11: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
Exhibit 12: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients: Segmentation by Type of Product 2014
Exhibit 13: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 14: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014-2019
Exhibit 15: Global High-potency Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
Exhibit 16: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
Exhibit 17: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 18: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player 2014
Exhibit 19: Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 20: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014
Exhibit 21: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014-2019
Exhibit 22: Active Pharmaceutical Ingredients Market in Americas 2014-2019 (US$ billion)
Exhibit 23: Active Pharmaceutical Ingredients Market in Americas: Segmentation by Key Leading Country 2014
Exhibit 24: Active Pharmaceutical Ingredients Market in APAC Region 2014-2019 (US$ billion)
Exhibit 25: Active Pharmaceutical Ingredients Market in APAC Region: Segmentation by Key Leading Country 2014
Exhibit 26: Active Pharmaceutical Ingredients Market in EMEA Region 2014-2019 (US$ billion)
Exhibit 27: Active Pharmaceutical Ingredients Market in EMEA Region: Segmentation by Key Leading Countries 2014
Exhibit 28: Global Active Pharmaceutical Ingredients Market: Key Leading Countries 2014
Exhibit 29: WHO’s List of Prequalified Active Pharmaceutical Ingredients (22nd October, 2014)
Exhibit 30: Aurobindo Pharma: Business Segmentation
Exhibit 31: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
Exhibit 32: BASF: Business Segmentation 2013
Exhibit 33: BASF: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 34: BASF: Geographical Segmentation by Revenue 2013
Exhibit 35: Boehringer Ingelheim: Business Segmentation by Revenue 2013
Exhibit 36: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 37: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
Exhibit 38: Cipla: Product Segmentation
Exhibit 39: Cipla: Geographical Segmentation by Revenue 2014
Exhibit 40: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2014
Exhibit 41: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
Exhibit 42: Dr. Reddy’s Laboratories: Geographical Segmentation by Revenue 2014
Exhibit 43: Lonza Group: Business Segmentation by Revenue 2013
Exhibit 44: Lonza Group: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 45: Lonza Group: Geographical Segmentation by Revenue 2013
Exhibit 46: Teva Pharmaceutical Industries: Business Segmentation
Exhibit 47: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
Exhibit 48: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 49: Teva Pharmaceutical Industries: Sales by Geography 2013
【レポート販売概要】
■ タイトル:医薬品有効成分(原薬/API)の世界市場■ 英文:Global Active Pharmaceutical Ingredients Market 2015-2019
■ 発行日:2014年12月10日
■ 調査会社:Technavio
■ 商品コード:IRTNTR4885
■ 調査対象地域:グローバル
- マイクロプロセッサ及びGPUの世界市場予測(~2022年)“The global microprocessor and GPU market is expected to grow at a CAGR of 2.2% between 2017 and 2022”The market is expected to be worth USD 83.69 billion by 2022, growing at a CAGR of 2.2% between 2017 and 2022. The growing demand for wearable devices such as smartwatches, migration of data from on-premise environments to cloud-based server environments, and impact of Internet of Things (IoT) are …
- 帯ひもの世界市場分析:製品別(ポリエステル、ナイロン、ポリプロピレン、炭素繊維、パラアラミド合成繊維、UHMWPE)、用途別(自動車および輸送、スポーツ用品、家具、軍用/防衛)、セグメント予測、-2020The Global Webbing Market is expected to reach USD 3.52 billion by 2020, according to a new study by Grand View Research, Inc. Webbing demand is expected to grow with widening application scope including seat belts, safety harnesses and towing straps in automotive and transportation. Increasing construction spending coupled with growth in automotive manufacturing is expected to be critical for mar …
- 害虫駆除の世界市場展望2017-2026According to Stratistics MRC, the Global Pest Control Market is accounted for $17.87 billion in 2017 and is expected to reach $33.13 billion by 2026 growing at a CAGR of 7.1% during the forecast period. Growing urbanization coupled with the exponential growth of population, effects of climate change on pest proliferation and easy availability of pest control products & services are some of the fac …
- 世界の自動支出分析ソリューション市場:Global Automated Spend Analysis Solutions Market 2014-2018TechNavio's analysts forecast the Global Automated Spend Analysis Solutions market to grow at a CAGR of 13.64 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing need for expense visibility for intelligent decision making. The Global Automated Spend Analysis Solutions market has also been witnessing the emergence of SaaS-based spend analys …
- ルテインの世界市場Lutein (CAS 127-40-2) Market Research Report 2013 presents comprehensive data on lutein markets globally and regionally (Europe, Asia, North America etc.) The Lutein (CAS 127-40-2) Market Research Report 2013 includes lutein description, covers its application areas and related patterns. It overviews lutein market, names lutein producers and indicates its suppliers. Besides, the Lutein (CAS 127-40 …
- Oil India Limited:石油・ガスバリューチェーン分析レポート2013Oil India Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Oil India Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Oil India Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the …
- ペーシェント・フロー・マネージメント(PFM)ソリューションの世界市場、患者管理、ITシステム、導入、リアルタイム位置、患者追跡The healthcare industry is undergoing a fundamental transformation globally as it shifts from a volume-based business to a value-based business. Growing demands from consumers for improved healthcare quality and greater value are forcing healthcare providers and payers to deliver optimized outcomes. In addition, the number of hospital admissions is rising globally but the healthcare infrastructure …
- 下大静脈(IVC)フィルター(医療機器)のグローバル新興国市場(2012-2018)BRICSS IVC Filter Devices market value is expected to reach US$71 million by 2016, primarily supported by the product types - Retrievable Filters and Permanent IVC Filters. China accounts for nearly 33% of the market share and India claims more than 24%. In terms of CAGR, China is the fastest growing region while India and Russia are just behind. Among the product types, Retrievable IVC Filters ma …
- クロールアルカリ(Chlor-Alkali)製品の世界市場:塩素、苛性曹達、ソーダ灰などChlorine, caustic soda and soda ash are widely used in the global chemical, glass, plastic and various other industries. In 2013, the three products of chlor-alkali had total demand of 187,919KT globally. The Asia-pacific region is the biggest market of chlor-alkali products, accounting for more than half of the total global demand. There is a lot of scope in Asian and European market, with the bo …
- Idemitsu Kosan Co., Ltd.:石油・ガスの開発・生産動向及びコスト分析- 2012Idemitsu Kosan Co., Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Idemitsu Kosan Co., Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 石油&ガス掘削自動化の世界市場予測・分析2020-2024Global Oil and Gas Drilling Automation Market: About this market Technavio’s oil and gas drilling automation market analysis considers sales from both onshore and offshore applications. Our study also finds the sales of oil and gas drilling automation in APAC, Europe, MEA, North America, and South America. In 2019, the onshore segment had a significant market share, and this trend is expected to c …
- 使い捨て保護服の世界市場:材料別(ポリエチレン、ポリプロピレン、ポリエステルなど)、用途別(熱、機械、化学、放射線、その他)、最終用途産業別(製造、石油およびガス、ヘルスケア、防衛、その他)The global disposable protective clothing market was valued at $2,604.0 million in 2018 and is projected to reach $4,686.8 million by 2026, growing at a CAGR of 6.80% from 2019 to 2026. Protective clothing refers to various suits and uniforms worn to protect the user from harm. Protective clothing protects the personnel from physical, electrical, heat, chemicals, biohazards, and airborne particula …
- 液体洗剤の世界市場2015-2019Global Liquid Detergent Market 2015-2019 Covering: This market research report presents the segmentation of the global liquid detergent market by retail format (hypermarkets and supermarkets, independent stores, and convenience stores) and by geography (Americas, APAC, Europe, and MEA). The report also includes an insightful analysis of the leading companies in the market such as Church & Dwight, …
- 世界の先進運転支援システム(ADAS)市場における主要企業分析As Automated Parking, Adaptive Cruise Control and other ADAS End-User Applications expand from the high-end to mid-range car segment and the NHTSA announces its rear-view camera mandate in North America, our focus is on identifying which company leads the ADAS Market in 2014 and why. As the race towards autonomous vehicles continues, it is incremental to establish the shares of the leading Supplie …
- 肝損傷(Hepatic Injury):世界の治験レビュー(2015年上半期版)Hepatic Injury Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Injury. It includes an overview of the trial numbers and their recruitment status as per …